NCT03157050

Brief Summary

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 14, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 16, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
Last Updated

May 17, 2017

Status Verified

May 1, 2017

Enrollment Period

1.3 years

First QC Date

May 16, 2017

Last Update Submit

May 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in patient health questionnaire-9 score

    change in patient health questionnaire-9 score before and after intravenous iron therapy

    on day 0 of start of intravenous iron and 1 week after completion of intravenous iron

Interventions

each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hemodialysis patients with iron deficiency anemia.

You may qualify if:

  • age was above 19 years,
  • patient on maintenance hemodialysis,
  • patient had iron deficiency anemia (ferritin \> 100 ng/ml)

You may not qualify if:

  • patient has history of depression or already using antidepressant medication,
  • Lack of ferritin level increase ≥ 50% from baseline level before IV iron administration,
  • patient already on oral or intravenous iron supplement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DepressionAnemia, Iron-Deficiency

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorAnemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Mahmoud Hamada, MD

    Benha University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Internal Medicine - Faculty of Medicine

Study Record Dates

First Submitted

May 16, 2017

First Posted

May 17, 2017

Study Start

January 14, 2016

Primary Completion

May 15, 2017

Study Completion

May 16, 2017

Last Updated

May 17, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share